In summary, the results of this study provide experimental evidence for the effectiveness of combined treatment with TMZ and eEF-2 kinase inhibitors in treating glioma, and suggest that this approach may be worth further exploring as a therapeutic strategy against malignant brain tumor. This evidence concerns the gene EEF2K and glioma.